TransMedics Group (TMDX) PT Lowered to $110 at Baird

October 15, 2026 7:22 AM

Baird analyst David Rescott lowered the price target on TransMedics Group (NASDAQ: TMDX) to $110.00 (from $122.00) while maintaining a Outperform rating.

No results found